Paul V. O'Donnell, MD, PhD [clinicaltrials_resource:b634c9386a868d0b51d3af299c3d4227]
Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003960]Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003962]Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer [clinicaltrials:NCT00346359]
overall official [clinicaltrials_vocabulary:overall-official]
Paul V. O'Donnell, MD, PhD [clinicaltrials_resource:b634c9386a868d0b51d3af299c3d4227]
Bio2RDF identifier
b634c9386a868d0b51d3af299c3d4227
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b634c9386a868d0b51d3af299c3d4227
affiliation [clinicaltrials_vocabulary:affiliation]
last name [clinicaltrials_vocabulary:last-name]
Paul V. O'Donnell, MD, PhD
role [clinicaltrials_vocabulary:role]
Study Chair
identifier
clinicaltrials_resource:b634c9386a868d0b51d3af299c3d4227
title
Paul V. O'Donnell, MD, PhD
@en
type
label
Paul V. O'Donnell, MD, PhD [clinicaltrials_resource:b634c9386a868d0b51d3af299c3d4227]
@en